Physician profile
James Vincent Cornetta
NPI 1689665861
$1,535.85
in general payments reported to CMS, 2019-2025
20 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $93.46 · 2021: $252 · 2022: $313 · 2023: $299 · 2024: $103 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $257.49 | 2019-2024 | Total30 |
| Harrow Eye, LLC | $148.46 | 2025 | Vevye |
| Kala Pharmaceuticals, INC. | $137.46 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $130.64 | 2023 | Clarus |
| Abbvie INC. | $123.90 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $117.21 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $111.15 | 2023 | Infuse |
| Genzyme Corporation | $104.22 | 2019 | |
| Sun Pharmaceutical Industries INC. | $88.29 | 2024 | |
| Allergan, INC. | $87.91 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $33.87 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.82 | 2019-2020 | |
| Oyster Point Pharma, INC. | $27.47 | 2022 | |
| Lkc Technologies, INC. | $25.98 | 2025 | |
| Biotissue Holdings INC. | $24.01 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $22.18 | 2019-2020 | |
| Coopervision INC. | $19.73 | 2021 | |
| Shire North American Group INC | $16.49 | 2019 | |
| Optos, INC. | $15.10 | 2022 | |
| Dompe US, INC. | $13.47 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cornetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.